Medical Condition News

RSS

Secondhand nicotine vaping at home may increase risk of bronchitic symptoms in young adults

Secondhand exposure at home to the nicotine vapour from e-cigarettes is linked to a heightened risk of bronchitic symptoms and shortness of breath among young adults, finds research published online in the respiratory journal Thorax.

11 Jan 2022

Psychotropic drugs are commonly used by patients with heart disease, study shows

Antidepressants and other psychiatric medications are associated with an almost doubled risk of premature death in patients with heart conditions, according to research published today in the European Journal of Cardiovascular Nursing, a journal of the European Society of Cardiology (ESC).

11 Jan 2022

Neurologist receives ERC grant to study novel light-activated drugs with antiepileptic effects

Dr. Michael Wenzel from the Department of Epileptology at the University Hospital Bonn has received a coveted Starting Grant from the European Research Council.

10 Jan 2022

Poor cognition may be part of normality in older age, research says

At the first sign of cognitive trouble, people often worry Alzheimer's disease is forthcoming. But poor cognition can be part of the spectrum of normality in older age, according to new research published in JNeurosci.

10 Jan 2022

Research may lead to new treatment options for Crohn's disease patients

Results of a new study by researchers at Case Western Reserve University represent a step toward improving our understanding of Crohn's disease and the factors that cause its intestinal inflammation.

10 Jan 2022

Improving air quality may reduce dementia risk in older women

Improving air quality appears to slow cognitive decline and reduce the risk of developing dementia in older women living in the U.S., according to a new study by researchers from the Keck School of Medicine of USC.

10 Jan 2022

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Translocation renal cell carcinoma (tRCC) is a rare and aggressive form of kidney cancer. It accounts for about 5 percent of all renal cell carcinomas in adults and about 50 percent in children.

10 Jan 2022

Higher olive oil consumption linked with lower risk of cardiovascular disease, cancer mortality

Consuming more than 7 grams (>1/2 tablespoon) of olive oil per day is associated with lower risk of cardiovascular disease mortality, cancer mortality, neurodegenerative disease mortality and respiratory disease mortality, according to a study publishing today in the Journal of the American College of Cardiology.

10 Jan 2022

New grant program launches to advance therapeutic discovery for follicular lymphoma

Today saw the launch of a dedicated grant program aimed at advancing therapeutic discovery for follicular lymphoma (FL), The Follicular Lymphoma Foundation (FLF) CURE FL Awards - Curative Research to Eliminate Follicular Lymphoma.

10 Jan 2022

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

The National Comprehensive Cancer Network today announced the publication of new NCCN Guidelines for Patients: Graft-Versus-Host Disease (GVHD).

10 Jan 2022

Scientists shine new light on the complexity of vitamin B12 diseases

A team of researchers at Baylor College of Medicine and collaborating institutions has shed new light into the complexity of vitamin B12 diseases.

10 Jan 2022

JPND announces call for multinational research on understanding the mechanisms of non-pharmacological interventions

The EU Joint Programme - Neurodegenerative Disease Research (JPND) initiative has announced a joint transnational call for multinational research on understanding the mechanisms of non-pharmacological interventions.

10 Jan 2022

Mapping regulatory T-cell populations in COVID-19 patients

In a new study, researchers used mass spectrometry to investigate changes to immune systems, in particular regulatory T-cells (Tregs), in a large cohort of moderate, severe, and critical Japanese coronavirus disease 2019 (COVID-19) patients and healthy controls.

10 Jan 2022

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

New research suggests that viral mutations have a minimal effect on T cell immunity, which could explain the protection provided by vaccination against severe COVID-19, despite the significant loss of neutralizing antibodies.

10 Jan 2022

Warming planet may increase the burden of kidney stone disease on healthcare systems

Rising temperatures due to climate change will lead to an increase in cases of kidney stones over the next seven decades, even if measures are put in place to reduce greenhouse gas emissions, according to a new study by researchers at Children's Hospital of Philadelphia.

10 Jan 2022

Researchers discover a potential depression biomarker and why it affects women and men differently

A team of Université Laval scientists may have discovered why severe depression affects women and men differently, according to a study published today in Nature Communications.

10 Jan 2022

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting targets to reduce heart disease risk. Fortunately, available therapies can help when combined with new approaches that address social determinants of health and other barriers to care, according to a new American Heart Association scientific statement published today in the Association's flagship journal Circulation.

10 Jan 2022

Study finds novel pathway for understanding why debilitating conditions happen for cancer patients

Severe and persistent disability often undermines the life-saving benefits of cancer treatment. Pain and fatigue - together with sensory, motor, and cognitive disorders - are chief among the constellation of side effects that occur with the platinum-based agents used widely in chemotherapy treatments worldwide.

9 Jan 2022

Blood test plus risk model can accurately determine who may benefit from lung cancer screening

A blood test, combined with a risk model based on an individual's history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study published today in the Journal of Clinical Oncology led by researchers from The University of Texas MD Anderson Cancer Center.

9 Jan 2022

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Millions of people around the globe are affected by cancer each year; more than 39% of men and women are diagnosed with cancer during their lifetime.

7 Jan 2022

Medical Condition News

Secondhand nicotine vaping at home may increase risk of bronchitic symptoms in young adults

Psychotropic drugs are commonly used by patients with heart disease, study shows

Neurologist receives ERC grant to study novel light-activated drugs with antiepileptic effects

Poor cognition may be part of normality in older age, research says

Research may lead to new treatment options for Crohn's disease patients

Improving air quality may reduce dementia risk in older women

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Higher olive oil consumption linked with lower risk of cardiovascular disease, cancer mortality

New grant program launches to advance therapeutic discovery for follicular lymphoma

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

Scientists shine new light on the complexity of vitamin B12 diseases

JPND announces call for multinational research on understanding the mechanisms of non-pharmacological interventions

Mapping regulatory T-cell populations in COVID-19 patients

SARS-CoV-2 viral mutations shown to have a limited effect on T cell immunity

Warming planet may increase the burden of kidney stone disease on healthcare systems

Researchers discover a potential depression biomarker and why it affects women and men differently

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Study finds novel pathway for understanding why debilitating conditions happen for cancer patients

Blood test plus risk model can accurately determine who may benefit from lung cancer screening

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News